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The role of neuronal dendrites is to receive and pro-
cess synaptic inputs. The geometry of the dendritic
arbor can undergo neuronal activity-dependent
changes that may impact the cognitive abilities of
the organism. Here we show that vascular endothe-
lial growth factor D (VEGFD), commonly known as
an angiogenic mitogen, controls the total length
and complexity of dendrites both in cultured hippo-
campal neurons and in the adult mouse hippocam-
pus. VEGFD expression is dependent upon basal
neuronal activity and requires nuclear calcium-
calmodulin-dependent protein kinase IV (CaMKIV)
signaling. Suppression of VEGFD expression in the
mouse hippocampus by RNA interference causes
memory impairments. Thus, nuclear calcium-VEGFD
signaling mediates the effect of neuronal activity on
the maintenance of dendritic arbors in the adult
hippocampus and is required for cognitive func-
tioning. These results suggest that caution be em-
ployed in the clinical use of blockers of VEGFD
signaling for antiangiogenic cancer therapy.
INTRODUCTION
Many brain functions, including memory formation and acquired
neuroprotection, are controlled by transient increases in the
intracellular calcium concentration induced by synaptic activity
(Hardingham and Bading, 2010; Silva et al., 1998). Calcium can
act locally near the site of entry to switch on signaling mecha-
nisms that modulate several biochemical processes that in turn
lead to changes in neuronal excitability and/or the efficacy of
synaptic transmission (Bliss et al., 2007). The long-term mainte-
nance of such activity-induced, functional adaptations requires
that calcium transients invade the cell nucleus and activate or
repress gene expression (Hardingham and Bading, 2010; Greer
and Greenberg, 2008). Nuclear calcium is one of the most potent
signals in neuronal gene expression and represents a key player
in the dialog between synapse and nucleus (Zhang et al., 2009). It
controls cAMP response element binding (CREB)- and CREB-binding protein (CBP)-mediated transcription (Hardingham
et al., 1997, 1999, 2001; Chawla et al., 1998; Hu et al., 1999)
and is critical for the acquisition of memories and the build-up
of neuroprotective activity in synaptically activated neurons
(Limba¨ck-Stokin et al., 2004; Papadia et al., 2005; Zhang et al.,
2007, 2009). A picture of how genomic events induced by
nuclear calcium signaling regulate persistent neuroprotection is
emerging (Zhang et al., 2009, 2011; Lau and Bading, 2009). In
contrast, nuclear calcium-regulated processes required for
memory formation are unknown. Here we considered the possi-
bility that nuclear calcium signaling modulates structural
features of neurons, in particular the complexity of the dendritic
arbor, that determine their ability to receive and process inputs
(Cline and Haas, 2008). The calcium/calmodulin-dependent
protein kinase IV (CaMKIV), a target of calcium in the nucleus
(Chow et al., 2005), has been implicated in the regulation of
dendritic growth and spine remodeling (Redmond et al., 2002;
Marie et al., 2005), suggesting that nuclear calcium may repre-
sent an important signal in these processes. In this study we
identify vascular endothelial growth factor D (VEGFD), a mitogen
for endothelial cells and regulator of angiogenesis and lymphatic
vasculature (Lohela et al., 2009), as a target of nuclear calcium-
CaMKIV signaling in hippocampal neurons. We also show that
VEGFD is required for the maintenance of a complex dendritic
arbor and provides the molecular link between neuronal activity,
the regulation of dendritic geometry, and cognitive functioning.RESULTS
Nuclear Calcium Controls Dendrite Geometry
and Spine Density
To investigate the role of nuclear calcium signaling in the regula-
tion of dendrite architecture, we expressedCaMBP4 in the nuclei
of hippocampal neurons. This protein contains four repeats of
the M13 calmodulin (CaM) binding peptide derived from the
rabbit skeletal muscle myosin light chain kinase (Wang et al.,
1995). CaMBP4 effectively inactivates the nuclear calcium/
CaM complex and blocks genomic responses induced by
nuclear calcium signaling (Zhang et al., 2007, 2009; Papadia
et al., 2005). Morphometric analyses revealed that, compared
to control, hippocampal neurons expressing CaMBP4 along
with humanized Renilla reniformis green fluorescent protein
(hrGFP) to visualize the cells showed a significant decreaseNeuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc. 117
Figure 1. Nuclear Calcium Signaling Regu-
lates Neuronal Morphology
(A) Representative micrographs of hippocampal
neurons transfected with an expression vector for
hrGFP or cotransfected with expression vectors
for hrGFP and CaMBP4 or for hrGFP and CaM-
KIVK75E. Scale bar = 20 mm.
(B and C) Quantification of total dendritic length
and Sholl analysis in hippocampal neurons trans-
fected with the indicated constructs.
(D) Representative micrographs of dendritic
spines of hippocampal neurons transfected as
indicated. Scale bar = 5 mm.
(E) Quantification of spine density of neurons
transfected as in (D).
(F and G) Cumulative frequency plots of spine
length and spine width in neurons transfected as
indicated. More than 1000 spines and 12 neurons
from a minimum of 3 independent preparations
were examined for each construct.
Statistically significant differences are indicated
with asterisks, **p < 0.005, ***p < 0.0005. Bars
represent mean ± SEM.
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Nuclear Calcium and VEGFD in Dendrite Geometryboth in the total dendritic length and in the complexity of the
dendrites assessed by Sholl analysis (Figures 1A–1C). Expres-
sion of CaMBP4 also caused a significant decrease in dendritic
spine density (Figures 1D and 1E) and a considerable shortening
and thinning of the remaining spines (Figures 1F and 1G). A
similar reduction in total dendritic length, dendritic complexity,
spine size, and spine density was observed in hippocampal
neurons expressing CaMKIVK75E, a dominant negative mutant
of CaMKIV (Anderson et al., 1997) (Figure 1). These results indi-
cate that nuclear calcium is an important signal in the control of
dendritic geometry and spine density.
Nuclear Calcium-CaMKIV Signaling Regulates
VEGFD Expression
We next aimed at identifying nuclear calcium/CaMKIV-regulated
genes that mediate the observed structural changes. Examina-
tion of transcriptome data obtained from hippocampal neurons
expressing CaMBP4 (Zhang et al., 2009) drew our attention to
VEGFD (also known as Fos-induced growth factor) (Lohela
et al., 2009). VEGFD is well known for its role in angiogenesis118 Neuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc.and lymphangiogenesis in healthy tissues
and in several types of cancer (Achen and
Stacker, 2008). VEGFD is detectable in
the nervous system (http://www.brain-
map.org/; Lein et al., 2007) but a function
for this secreted factor in neurons has not
been described, although two other
VEGF family members, VEGF (also
known as VEGFA) and VEGFC, have
been implicated in neurogenesis and
the maturation of newly born neurons
(Cao et al., 2004; Le Bras et al., 2006;
Licht et al., 2010). Quantitative reverse
transcriptase PCR (QRT-PCR) analysis
revealed that VEGFD is expressed incultured hippocampal neurons and reaches peak levels of
expression after a culturing period of 10–13 days (Figure 2A
and Figure S1A, available online). VEGFD mRNA and protein
are detectable in cultured neurons and in vivo at different devel-
opmental stages in the mouse hippocampus and cortex (Figures
S1C–S1F). VEGFD expression is significantly lower in hippo-
campal neurons infected with a recombinant adenoassociated
virus (rAAV) containing an expression cassette for either
CaMBP4 (rAAV-CaMBP4) or CaMKIVK75E (rAAV-CaMKIVK75E)
than in uninfected neurons or in neurons infected with an
rAAV-expressing LacZ (rAAV-LacZ) (Figure 2B and Figure S1A).
The expression levels of many other genes, including other
members of the VEGF family, were not affected by CaMBP4 or
CaMKIVK75E (Zhang et al., 2009) (Figure S1B). The neurotrop-
ism of our rAAVs specifically targets neurons over glia (Xu
et al., 2001) indicating that the modulation of VEGFD expression
is restricted to neurons.
To investigate a possible contribution of neuronal activity to
VEGFD expression, we treated cultured hippocampal neurons
with TTX for 5 days (from day in vitro [DIV] 5 until the time point
Figure 2. VEGFD Expression Is Nuclear
Calcium Signaling/CBP Dependent
(A) QRT-PCR analysis of VEGFD expression in
hippocampal cultures at the indicated DIV (n = 5).
(B) QRT-PCR analysis of VEGFD expression in
uninfected hippocampal neurons and in hippo-
campal neurons infected with rAAVs giving rise to
the indicated proteins (n = 5).
(C) QRT-PCR analysis of VEGFD, VEGFC, cFos,
gapdh, b tubulin, and b microglobulin expression
in cultured hippocampal neurons on DIV 10 with or
without treatment from DIV 5 to DIV 10 with 1 mM
TTX (n = 3).
(D) QRT-PCR analysis of VEGFD, VEGFC, and
cFos expression in cultured hippocampal neurons
with or without treatment for 2 hr with 50 mM
bicuculline. VEGFD and VEGFC (y) axis scale is
shown on the left; cFos (y) axis scale is shown on
the right (n = 3).
(E) QRT-PCR analysis of VEGFD, VEGFC, and
cFos expression in cultured hippocampal neurons
with or without treatment from DIV 5 to DIV 10 with
10 mM MK801, 10 mM nifedipine, or both (n = 3).
(F) QRT-PCR analysis of expression of cFos and
VEGFD in uninfected hippocampal neurons and
in hippocampal neurons infected with rAAV-
CaMBP4 with or without treatment with actino-
mycin D (10 mg/ml) for 30 min, 1 hr, 2 hr, 4 hr, and
24 hr (n = 3).
(G) QRT-PCR analysis of expression of cFos and
VEGFD in uninfected hippocampal neurons and in
hippocampal neurons infected with rAAV-E1A or
rAAV-E1ADCR1 with or without treatment for 2 hr
with 50 mM bicuculline (bic). VEGFD (y) axis scale
is shown on the right; cFos (y) axis scale is shown
on the left (n = 3).
(H) QRT-PCR analysis of expression of GAPDH,
CBP, and VEGFD in hippocampal neurons with or
without treatment from DIV 8 to DIV 13 with the
indicated siRNAs (n = 3).
(I and J) Analysis of total dendritic length and Sholl
analysis of neurons infected with rAAV-E1A or
rAAV-E1ADCR1. Twelve neurons from a minimum
of three independent preparations were examined
for each construct.
Statistically significant differences are indicated
with asterisks (*p < 0.05, **p < 0.005, ***p <
0.0005). Bars represent mean ± SEM. See also
Figure S1.
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Nuclear Calcium and VEGFD in Dendrite Geometryof gene expression analysis on DIV 10). We found that compared
to controls, this treatment reduced expression of VEGFD and
also that of cFos, a well-characterized neuronal activity marker
(Figure 2C). For several other genes analyzed in parallel we found
no differences in expression levels after TTX treatment (Fig-
ure 2C). Given the prolonged duration of the TTX treatment, we
cannot rule out the possibility that the observed reduction in
VEGFD expression may be caused indirectly through secondary
effects. To determine if VEGFD mRNA levels are affected by an
increase in synaptic activity, we exposed hippocampal neurons
to the GABAA receptor blocker bicuculline. This treatment
relieves tonic, GABAA receptor-mediated inhibition of synaptic
transmission from the hippocampal network and induces burstsof action potentials (APs) (Hardingham et al., 2001; Arnold et al.,
2005). Bicuculline treatment caused a robust induction of cFos
mRNA but did not alter VEGFC or VEGFD mRNA levels (Fig-
ure 2D). To investigate the involvement of NMDA receptors
and voltage-gated calcium channels in VEGFD expression, we
treated hippocampal neurons with the NMDA receptor blocker
MK801 and/or nifedipine, a blocker of L-type voltage-gated
calcium channels. Both MK801 and nifedipine significantly
reduced the expression of VEGFD mRNA; treatment with a
combination of both channel blockers yielded the largest reduc-
tion in VEGFD mRNA levels (Figure 2E). These results indicate
that VEGFD expression is controlled by basal neuronal activity
through a mechanism that is initiated by NMDA receptors andNeuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc. 119
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Nuclear Calcium and VEGFD in Dendrite GeometryL-type voltage-gated calcium channels and requires nuclear
calcium-CaMKIV signaling.
Because the observed reduction of VEGFDmRNA levels after
inhibition of nuclear calcium signaling could be due to a change
in VEGFD mRNA stability, we next determined the half-life of
VEGFDmRNA. The levels of VEGFDmRNA and in parallel those
of cFos were measured in both uninfected and rAAV-CaMBP4-
infected hippocampal neurons before and at various time points
(0.5–24 hr) after treatment of the cells with actinomycin D, an
inhibitor of gene transcription. We found that VEGFD mRNA
has a half-life of more than 24 hr in uninfected hippocampal
neurons; a virtually identical decay rate for VEGFDwas observed
in rAAV-CaMBP4-infected neurons (Figure 2F), although com-
pared to uninfected controls, the absolute amounts of VEGFD
mRNA in these neurons were lower (see also Figure 2B and Fig-
ure S1A). Analysis of cFosmRNA revealed a half-life of less than
1 hr (Figure 2F), which is in agreement with other studies (Schiavi
et al., 1992). These results indicate that the regulation of VEGFD
expression by nuclear calcium signaling takes place at the level
of gene transcription rather than at the posttranscriptional level.
CBP Regulates VEGFD Expression
In silico analysis with the Transcription Element Search System
(TESS; http://www.cbil.upenn.edu/cgi-bin/tess/tess) of a 2000
base pairs-long upstream regulatory region of themurine VEGFD
gene revealed a large number of possible binding sites for
several transcription factors including the AP-1 complex,
NF-AT, MEF-2, HiNF, NF-kB, POU2-Oct, and HNF4. However,
a cAMP response element (CRE) appears to be lacking, suggest-
ing that nuclear calcium-CaMKIV-mediated regulation of VEGFD
takes place by transcription factors other than CREB, the proto-
typical target of this signaling pathway (Hardingham et al., 1997,
2001). Because the activity of the transcriptional coactivator
CBP is controlled by nuclear calcium and CaMKIV (Chawla
et al., 1998), we next tested the role of CBP in VEGFD regulation.
CBP interacts with a variety of transcription factors (Bedford
et al., 2010), which includes some of those for which putative
binding sites have been identified in the VEGFD gene (see
above). Moreover, a contribution of CBP to the regulation of
the human VEGFD promoter in cancer cells has been suggested
(Scha¨fer et al., 2008). To directly investigate a possible role of
CBP in the regulation of the endogenous VEGFD gene in hippo-
campal neurons, we infected the neurons with an rAAV express-
ing the adenovirus protein E1A. E1A binds to CBP via its amino
terminal-conserved region 1 (CR1) and disrupts CBP function
(Arany et al., 1995; Lundblad et al., 1995; Bannister and Kouzar-
ides, 1995). As expected, rAAV-mediated expression of E1A
blocked the AP bursting-induced increase in the expression of
cFos (Figure 2G), a known target of the CREB/CBP transcription
factor complex (Chawla et al., 1998; Hardingham et al., 1999;
Greer andGreenberg, 2008). Expression of E1A also significantly
reduced VEGFD mRNA levels (Figure 2G). Infection of hippo-
campal neurons with an rAAV expressing a mutant version
of E1A (E1ADCR1) that lacks CR1 and fails to interact with
CBP (Arany et al., 1995; Lundblad et al., 1995; Bannister and
Kouzarides, 1995) had no effect on cFos regulation or VEGFD
transcription (Figure 2G). We also used RNA interference
(RNAi) to specifically decrease CBP mRNA levels in hippo-120 Neuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc.campal neurons (Figure 2H). This caused a significant reduction
of VEGFD mRNA levels (Figure 2H) confirming the role of CBP
in modulating VEGFD transcription. A morphometric analysis re-
vealed that hippocampal neurons expressing E1A have shorter
and simplified dendritic trees compared to neurons expressing
E1ADCR1 (Figures 2I and 2J). These results indicate that CBP
acts downstream of nuclear calcium-CaMKIV signaling to regu-
late VEGFD expression in hippocampal neurons.
VEGFD Restores Dendrite Complexity but Not Spine
Density in Nuclear Calcium Signaling-Depleted Neurons
To investigate whether VEGFD is involved in mediating the
effects of nuclear calcium-CaMKIV signaling on neuronal struc-
ture, we either transfected or infected hippocampal neurons,
respectively, with an rAAV plasmid (pAAV-VEGFD) or an rAAV
(rAAV-VEGFD) containing an expression cassette for HA-tagged
VEGFD or we treated the neurons with recombinant VEGFD
(rVEGFD). Expression of HA-tagged VEGFD was detected im-
munocytochemically and by immunoblotting in rAAV-VEGFD-in-
fected hippocampal neurons and in the culture media (Figures
S1G and S1H). Although VEGFD-HA expression or exogenously
applied rVEGFD had no detectable effect on neuronal
morphology, both treatments rescued the reduction in dendrite
length and complexity caused by expression of CaMBP4 or
CaMKIVK75E (Figures 3A–3C, 3E, and 3F). In contrast,
VEGFD-HA and rVEGFD failed to restore normal spine density
in CaMBP4 or CaMKIVK75E-expressing neurons (Figures 3D
and 3G), indicating that the mechanisms through which nuclear
calcium-CaMKIV signaling regulate dendrite geometry and spine
density are distinct. Because VEGFD belongs to a family of
closely related factors that in part share the receptors (Achen
and Stacker, 2008), we tested whether VEGF or VEGFC also
affect dendrite arborization. However, neither recombinant
VEGF (rVEGF) nor recombinant VEGFC (rVEGFC) was able to
rescue the reduction in dendrite length and complexity caused
by CaMBP4 or CaMKIVK75E expression (Figure S2), indicating
a specific role for VEGFD in the control of dendrite arborization
by nuclear calcium-CaMKIV signaling.
VEGFD Autocrine Signaling Is Essential for Complex
Dendritic Arborization
To determine whether the observed reduction in VEGFD expres-
sion that followed blockade of nuclear calcium-CaMKIV
signaling is sufficient to alter dendritic architecture, we used
RNAi to lower VEGFD expression in hippocampal neurons.
DNA sequences encoding short hairpin RNAs (shRNAs) de-
signed to target the mouse VEGFD mRNA were inserted down-
stream of the U6 promoter of an rAAV vector. The resulting rAAV,
rAAV-shVEGFD, also harbors a calcium/calmodulin-dependent
protein kinase II (CaMKII) promoter-containing expression
cassette for the red fluorescent protein, mCherry (Figure 4A).
Control rAAVs were identical to rAAV-shVEGFD except that
they either lacked DNA sequences encoding shRNAs (rAAV-
emptymC) or contained DNA sequences encoding a scrambled
version of the VEGFD-specific shRNA (rAAV-shSCR). Infection
rates of 80%–95% of the neuron population were obtained for
all three rAAVs (Figures S3A and S3B). QRT-PCR and immuno-
blot analysis revealed that rAAV-shVEGFD, but not rAAV-shSCR
Figure 3. VEGFD Regulates Dendrite Archi-
tecture
(A) Representative micrographs of neurons trans-
fected with expression vectors for the indicated
proteins with or without treatment for 3 days with
rVEGFD (100 ng/ml). Scale bar = 20 mm.
(B–D) Sholl analysis and analysis of total dendritic
length and spine density of neurons transfected,
as indicated, with expression vectors for hrGFP,
CaMBP4, CaMKIVK75E, and VEGFD-HA.
(E–G) Sholl analysis and analysis of total dendritic
length and spine density of neurons transfected
with expression vectors for hrGFP, CaMBP4, and
CaMKIVK75E with or without treatment for 3 days
with rVEGFD. Twelve neurons from a minimum of
three independent preparations were examined
for each construct.
Statistically significant differences are indicated
with asterisks (*p < 0.05, **p < 0.005, ***p <
0.0005). Bars represent mean ± SEM. See also
Figure S2.
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Nuclear Calcium and VEGFD in Dendrite Geometryor rAAV-emptymC, reduced VEGFD mRNA levels and blocked
VEGFD protein expression (Figure 4B and Figure S3C). Expres-
sion of VEGFC was not affected by rAAV-shVEGFD or by the
two control rAAVs (Figure 4B). It has been reported that expres-
sion of certain shRNAs can have an effect on neuronal mor-
phology because of the induction of an interferon response
(Alvarez et al., 2006). However, by using an interferon-responsive
reporter gene system we found no evidence for an interferon
response induced by rAAV-shVEGFD (Figure S3D). In addition,
we observed no increase in cell death in hippocampal neurons
infected with rAAV-shVEGFD (Figure S3E).
Morphological analyses revealed that compared to hippo-
campal neurons transfected with pAAV-shSCR or pAAV-emp-
tymC, neurons transfected with pAAV-shVEGFD showed a less
complex dendritic arbor and a reduction in total dendritic lengthNeuron 71, 117–(Figures 4C–4E). In contrast, RNAi-medi-
ated knockdown of VEGFD did not
change spine density (number of spines/
20 mm: 7.1 ± 0.36, pAAV-emptymC;
6.17 ± 0.56, pAAV-shSCR; 6.52 ± 0.51,
pAAV-shVEGFD). Similar results were ob-
tained with different shRNA sequences
directed against VEGFD (Figure S3F and
Supplemental Experimental Procedures).
The effect of pAAV-shVEGFD transfec-
tion on the dendritic tree could be re-
versed by treatment with rVEGFD. In
contrast, rVEGFD did not affect dendrite
length or complexity of hippocampal
neurons transfected with pAAV-shSCR
and pAAV-emptymC (Figures 4C–4E).
These results identify a role for VEGFD
in the regulation of dendritic architecture
and further support the above-mentioned
concept (see Figure 3) that dendrite
arborization and spine morphogenesisare controlled by distinct nuclear calcium/CaMKIV-regulated
processes.
The observation that the dendrite structure is altered in
shVEGFD-expressing neurons even if the surrounding untrans-
fected cells have a normal VEGFD expression level suggests
a possible autocrine mechanism of action of VEGFD. To inves-
tigate this further, we transfected hippocampal neurons with
pAAV-VEGFD-HA or with a plasmid containing an expression
cassette for HA-tagged VEGFD resistant to shVEGFD (pAAV-
resiVEGFD-HA) together with pAAV-shVEGFD in order to over-
express VEGFD in the same neurons expressing shVEGFD.
Expression of resiVEGFD-HA rescued the reduction of dendrite
length and complexity caused by expression of shVEGFD
(Figures 4F–4H), indicating that VEGFD acts in an autocrine
manner. This conclusion is further supported by an experiment130, July 14, 2011 ª2011 Elsevier Inc. 121
Figure 4. RNAi-Mediated Suppression of
VEGFD Expression Is Sufficient to Alter
Dendritic Morphology
(A) Schematic representation of the rAAV vector
used for shRNA expression.
(B) QRT-PCR analysis of expression of VEGFD
and VEGFC in uninfected hippocampal neurons
and in hippocampal neurons infected with rAAV-
emptymC, rAAV-shVEGFD, or with rAAV-shSCR
(n = 5).
(C) Representative micrographs of hippocampal
neurons transfected with pAAV-emptymC, pAAV-
shVEGFD, or pAAV-shSCR with or without treat-
ment for 3 days with rVEGFD (100 ng/ml). The
mCherry signal was used to visualize the neurons.
Scale bar = 20 mm.
(D and E) Sholl analysis and analysis of total
dendritic length of neurons transfected as in (C)
and, where indicated, treated with rVEGFD.
Twelve neurons from a minimum of three inde-
pendent preparations were examined for each
construct.
(F) Analysis of total dendritic length of neurons
transfected as in (G). Twelve neurons from a
minimum of three independent preparations were
examined for each construct.
(G) Representative micrographs of hippocampal
neurons transfected with pAAV-hrGFP (vector),
pAAV-VEGFD-HA, or pAAV-resiVEGFD-HA with
or without cotransfection with pAAV-shVEGFD.
Scale bar = 20 mm.
(H) Sholl analysis of neurons transfected as in (G).
Twelve neurons from a minimum of three inde-
pendent preparations were examined for each
construct.
Statistically significant differences are indicated
with asterisks (*p < 0.05, **p < 0.005, ***p <
0.0005). Bars represent mean ± SEM. See also
Figure S3.
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VEGFD and subsequently transfected with pAAV-shVEGFD.
Because infection rates are very high but transfection rates
are very low, this creates a situation in which a small number
of transfected cells with low VEGFD expression levels and
reduced dendrite length and arborization are surrounded by in-
fected cells overexpressing VEGFD. We found that even under
these conditions the impairment in dendrite morphology caused
by shVEGFD cannot be overcome by the VEGFD overex-
pressed in the infected neurons (Figures S3G–S3I). Thus,
although we cannot fully exclude paracrine action of VEGFD,
all available evidence strongly suggests that VEGFD regulates
total dendrite length and complexity through an autocrine
mechanism.122 Neuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc.VEGFD Regulates Dendritic
Arborization via VEGFR3
Human VEGFD and its close relative
VEGFC can bind and activate both VEGF
receptors 2 and 3 (VEGFR2 andVEGFR3);
however,murineVEGFDcanonly activate
VEGFR3 (Baldwin et al., 2001). To investi-gate whether dendritic architecture is specifically controlled by
VEGFD acting via VEGFR3, we generated rAAVs expressing
shRNAs specific for VEGF (rAAV-shVEGF), VEGFC (rAAV-
shVEGFC), and VEGFR3 (rAAV-shVEGFR3) (Wong et al., 2005;
Kleinman et al., 2008). By using QRT-PCR we showed that
rAAV-shVEGF, rAAV-shVEGFC, rAAV-shVEGFR3, and rAAV-
shVEGFD reduced mRNA levels of their respective targets
leaving unaltered the expression of the other VEGF family
members (Figure 5A). Morphological analyses revealed that
transfection of hippocampal neurons with pAAV-shVEGF or
pAAV-shVEGFC, similar to transfection with the control plas-
mids, pAAV-shSCRorpAAV-emptymC, hadnoeffect ondendrite
length or complexity (Figures 5B–5D). In contrast, knockdown of
VEGFR3 by transfecting neurons with pAVV-shVEGFR3 led to
Figure 5. RNAi-Mediated Suppression of
VEGFR3 Causes the Same Simplified
Dendritic Arborization Phenotype Observed
by Silencing VEGFD
(A) QRT-PCR analysis of expression normalized to
uninfected cells of VEGFD, VEGF, VEGFC, and
VEGFR3 in uninfected hippocampal neurons
and in hippocampal neurons infected with rAAV-
emptymC, rAAV-shVEGFD, rAAV-shVEGF, rAAV-
shVEGFC, or rAAV-shVEGFR3 (n = 3).
(B) Representative micrographs of hippocampal
neurons transfected with pAAV-emptymC, pAAV-
shSCR, pAAV-shVEGFD, pAAV-shVEGF, pAAV-
shVEGFC, or pAAV-shVEGFR3. The mCherry
signal was used to visualize the neurons. Scale
bar = 20 mm.
(C and D) Sholl analysis (C) and analysis of total
dendritic length (D) of neurons transfected as in
(B). Twelve neurons from a minimum of three
independent preparations were examined for
each construct. Statistically significant differences
are indicated with asterisks (*p < 0.05, **p < 0.005).
Bars represent mean ± SEM.
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to those obtained in hippocampal neurons transfected with
pAAV-shVEGFD (Figures 5B–5D; see also Figures 4C–4H and
Figures S3G–S3I for the effects of pAAV-shVEGFD on dendrite
morphology). These results indicate that among VEGF family
members, VEGFD, acting through VEGFR3, plays a specific
role in the regulation of dendrite arborization.
VEGFD Regulates Multiple Signaling Pathways
in Hippocampal Neurons and Shapes Dendrite
Morphology via p38 MAP Kinase Activation
We next determined the signaling mechanisms through which
VEGFD controls dendrite architecture. Cell lysates from hippo-Neuron 71, 117–campal neurons treated with rVEGFD
for various lengths of time were sub-
jected to immunoblot analysis by using
a large panel of antibodies that are
specific for the phosphorylated (i.e., acti-
vated) forms of signaling molecules (Fig-
ure 6). We found that rVEGFD activates
ERK1/2, p38 MAP kinase (MAPK), and
CREB (Figures 6A and 6B). The increase
in ERK1/2 phosphorylation and CREB
phosphorylation (which takes place in
neurons and not in glial cells as shown
by double immunostaining with the
neuronal marker NeuN; Figure 6C) was
significant but moderate (Figures 6A
and 6B). In contrast, the activation of
p38 MAPK was very robust (Figures 6A
and 6B), indicating that it may be a major
transducer of VEGFD signaling in hippo-
campal neurons. We therefore deter-
mined whether p38 MAPK mediates the
effects of VEGFD on dendrite geometry.Indeed, selective blockade of p38 MAPK by using the p38
MAPK inhibitor SB203580 severely compromised the ability of
rVEGFD to rescue the impairment of dendrite length and com-
plexity in hippocampal neurons expressing CaMBP4 and CaM-
KIVK75E (Figures 6D and 6E; see also Figures 3A, 3E, and 3F).
Because SB203580 inhibits the alpha and beta isoforms of
p38 MAPK (Bain et al., 2007), we further investigated the role
of p38 MAPK in VEGFD-mediated dendritic arborization by
RNAi. We generated two pAAVs, shp38a and shp38b, that
contain expression cassettes for shRNAs specific for the alpha
and the beta isoform, respectively, of p38 MAPK. We found
that the reduction of p38 alpha MAPK expression prevented
the rVEGFD-induced rescue of the dendrite phenotypes of130, July 14, 2011 ª2011 Elsevier Inc. 123
Figure 6. VEGFD-Induced Signaling Events
(A) Immunoblot analysis by using phosphospecific
antibodies of hippocampal neurons with or with-
out rVEGFD treatment for the indicated times.
Tubulin was used as loading control.
(B) Quantification of the experiment shown in (A).
rVEGFD treatment causes a significant increase of
CREB, ERK1/2, and p38 MAP kinase phosphory-
lation. All values are expressed as percentage of
untreated controls (n = 5).
(C) Immunocytochemical analysis by using phos-
pho-CREB-specific antibodies of hippocampal
neurons with or without rVEGFD treatment for the
indicated times. Nuclei of cells were counter-
stained with Hoechst 33258; NeuN was used as a
neuronal marker. Representative images are
shown. Scale bar = 20 mm.
(D) Analysis of total dendritic length of neurons
transfected with expression vectors for hrGFP,
CaMBP4, and CaMKIVK75E with or without
treatment for 3 days with rVEGFD and/or
SB203580. Twelve neurons from a minimum of
three independent preparations were examined
for each experimental condition.
(E) Sholl analysis of neurons transfected and
treated as in (D). Sholl analysis data of neurons
expressing hrGFP, CaMBP4, or CaMKIVK75E
treated with SB203580 showed no difference
compared to the respective untreated controls
and were omitted from the graph for clarity.
(F) Analysis of total dendritic length of neurons
transfected with expression vectors for hrGFP,
CaMBP4, shSCR, shp38a or shp38b (as indicated)
with or without treatment for 3 days with rVEGFD.
Twelve neurons from a minimum of three inde-
pendent preparations were examined for each
experimental condition. Statistically significant
differences are indicated with asterisks (*p < 0.05,
**p < 0.005, ***p < 0.0005). Bars represent
mean ± SEM.
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results indicate that p38 alpha MAPK is required for VEGFD
regulation of dendrite architecture.
VEGFD Modulates Network Activity
To investigate whether VEGFD-regulated changes in the struc-
ture of dendrites are associated with changes in neuronal
network activity, we used microelectrode array (MEA) record-
ings. Indeed, the spike frequencies of hippocampal cultures in-
fected with rAAV-shVEGFD were reduced compared to cultures124 Neuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc.infected with rAAV-shSCR or rAAV-
emptymC. This decrease could be partly
rescued by the addition of rVEGFD to
the media (Figure 7A). The decrease in
network activity caused by infection with
rAAV-shVEGFD was first observed at
DIV 10 (Figure 7A), coinciding with theonset of robust VEGFDmRNA expression in vitro (see Figure 2A
and Figure S1A).
Patch-Clamp Recordings Verify Reduced Surface Area
and Excitability after Silencing VEGFD Expression
The effects of silencing VEGFD expression on the electrical prop-
erties of neurons were investigated with whole-cell patch clamp
recordings (Table S1 and Figure 7B). Neurons either transfected
with pAAV-shVEGFD or infected with rAAV-shVEGFD showed, in
comparison to their respective control group, a markedly smaller
Figure 7. MEA and Patch-Clamp Analysis
Reveal Reduced Activity, Surface Area,
and Synaptic Transmission in shVEGFD-
Expressing Neurons
(A) MEA analysis of absolute spike frequencies
of uninfected hippocampal neurons and hippo-
campal neurons infected with rAAV-emptymC,
rAAV-shVEGFD, and rAAV-shSCR. Where indi-
cated, cultureswere treatedatDIV6with100ng/ml
rVEGFD. Statistically significant differences are
indicated with asterisks (*p < 0.05). Bars represent
mean ± SEM.
(B) Scatter plot showing the distribution and mean
(horizontal bars) membrane capacitance (Cm) of
transfected and infected neurons expressing
shVEGFD or shSCR. Statistically significant differ-
ences are indicated with asterisks (****p < 0.0001).
(C) Representative mEPSCs averaged from 160–
220 events in a pAAV-shVEGFD and apAAV-shSCR
transfected cell showing the rawaverage above and
the scaled average below.
(D) Representative responses to bath application of
AMPA (10 mM, black or red line) in the presence of
cyclothiazide (20 mM), TTX (1 mM), and gabazine
(5 mM) recorded from pAAV-shVEGFD and pAAV-
shSCR transfected cells.
(E–G) Scatter plots showing the distribution and
mean (horizontal bars) mEPSC IEI (E), mEPSC
amplitude (F), and AMPA response (G). Note the log
scale of the ordinate axis in (E) and (F). Significant
differences between shVEGFD-expressing cells
and their respective transfected or infected shSCR-
expressing controls are indicated (*p < 0.05, **p <
0.01, with Kolmogorov-Smirnov two-sample tests;
n = 26 to 31 cells per group). See also Table S1.
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surface area, a finding consistent with the observed reduction in
dendritic arborization (Figures 4 and 5). Despite this difference,
shVEGFD-expressing neurons did not show an altered resting
membrane potential or threshold membrane potential for action
potential initiation (Table S1). This reflects the healthy integrity of
these neurons despite their altered morphology. Slightly more
current injection was necessary to elicit an action potential in
shVEGFD-expressingcells,although this trendwasonlysignificant
in thegroupofhippocampalneurons inwhich infectionwasused to
express shVEGFD (Table S1). Moreover, we found stronger
accommodation in spike patterns induced by squarewave current
injections in shVEGFD-expressing neurons (data not shown). This
suggests a mildly reduced excitability in shVEGFD-expressing
neurons, consistent with the reduced absolute spike frequency
identified with MEA recordings (see Figure 7A). Increased accom-
modation may be due to a reduced contribution of dendritic
sodium channels, h-channels, or calcium-activated potassium
channels, which in pyramidal neurons can drive slow repetitive
firing and influence burst waveforms.Neuron 71, 117–Lowering VEGFD Expression
Reduces the Number of Functional
AMPA Receptors
The influence of VEGFD expression on
synaptic transmission in hippocampalneurons in culture was directly assessed by recording miniature
excitatory postsynaptic currents (mEPSCs) in the presence of
TTX and the GABAA receptor blocker, gabazine. Neurons trans-
fected with pAAV-shVEGFD or infected with rAAV-shVEGFD
showed longer mEPSC interevent intervals (IEIs, 1/frequency)
and smaller mEPSC amplitudes than their respective shSCR-
expressing controls (Figures 7E and 7F). The reduced mEPSC
frequency in transfected hippocampal neurons suggests that
the effect was not mediated by a reduced release probability
presynaptically because the low transfection rate ensures that
the majority of synaptic input to shRNA-expressing cells comes
from non-shRNA-expressing cells. The reduced mEPSC fre-
quency is thus most likely indicative of fewer AMPA receptor-
containing synapses per cell. The 21%–24% reduction in
mEPSC amplitude also suggests a lower density of AMPA recep-
tors at synapses in shVEGFD-expressing cells. mEPSCs of
hippocampal neurons expressing shVEGFD also showed faster
rise and decay time constants than their respective shSCR-ex-
pressing controls (Figure 7C and Table S1), most likely due to
reduced filtering of mEPSCs in their more compact dendritic130, July 14, 2011 ª2011 Elsevier Inc. 125
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component of the mEPSC may have been reduced in
shVEGFD-expressing neurons, although significant NMDA
currents are unlikely in our recording conditions (71mV holding
potential, 1.3 mM Mg2+). Responses were also recorded to
bath-applied AMPA, which produced a peak within 30 s whose
amplitude was used as an indication of the total number of func-
tional AMPA receptors per cell (Figure 7D). AMPA response
amplitudes were smaller in hippocampal neurons expressing
shVEGFD (Figures 7D and 7G), indicative of a reduced total
number of surface-expressed AMPA receptors per cell. Taken
together, our patch-clamp analysis has identified a reduced
plasma membrane surface area, as well as a reduced number
of AMPA receptor-containing synapses, a reduced number of
AMPA receptors per synapse, and a reduced total number of
AMPA receptors in shVEGFD-expressing cells. These results
are consistent with the reduced dendritic morphology identified
by morphometric analyses.
VEGFD Shapes Dendritic Arborization In Vivo
We next investigated the role of VEGFD in vivo. rAAV-shVEGFD
or the appropriate control rAAVs were stereotaxically delivered
to the dorsal hippocampus of 2-month-old C57BL/6 male
mice. Infected neurons were readily identified by analysis of
the mCherry fluorescence (Figure S4). The morphology of
neurons in the CA1 area of the hippocampus was assessed by
manually tracing the basal dendrites of Golgi-stained brain slices
obtained from animals 2.5 weeks after viral gene delivery. As in
cultured neurons, infection of hippocampal neurons in vivo
with rAAV-shVEGFD, but not with rAAV-shSCR or rAAV-emp-
tymC, reduced both the total length of dendrites and their
complexity (Figures 8A–8C).
VEGFD Is Required for Memory Formation
We finally investigated whether the changes in neuronal struc-
ture induced by RNAi-mediated knockdown of VEGFD causes
cognitive deficits. Mice stereotaxically injected with rAAV-
shVEGFD or rAAV-shSCR into the hippocampus were tested in
two well-characterized hippocampus-dependent memory tests:
Morris water maze and contextual fear conditioning. In the
hidden-platform version of the Morris water maze, mice learn
the location of the platform by using distal visual cues (Morris
et al., 1982). We found that mice stereotaxically injected with
rAAV-shSCR or rAAV-shVEGFD needed significantly less time
to find the hidden platform across training trials (main effect of
training session: F[7,91] = 11.30, p < 0.0001); however, no effect
of treatment was observed (main effect of treatment: F[1,13] =
1.34, p = NS) (Figure 8D). This suggests that both groups have
developed a learning strategy to find the hidden platform.
Multiple behavioral strategies may be employed by the mice to
obtain the reward (escape from water) and some of these strat-
egiesmay be comparably efficient but distinct in the requirement
for hippocampal function (Lipp and Wolfer, 1998; Gerlai, 2001).
To assess spatial memory, we performed a probe trial during
which the platform was removed from the water maze and the
mice were given 60 s to search for it. The search pattern during
the probe trial can reveal a spatial preference that is believed
to represent spatial memory. We observed that rAAV-shSCR-126 Neuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc.injected mice show a spatial preference for the target quadrant,
whereas rAAV-shVEGFD-injected mice did not (Figure 8E). This
was expressed as a significantly longer time spent in the target
quadrant by the rAAV-shSCR-injected mice in comparison
to the other quadrants (one-way analysis of variance [ANOVA]:
F[3,28] = 9.84, p < 0.001; multiple post hoc comparisons: time
in target quadrant versus time in adjacent or opposite quadrants;
p < 0.05). In contrast, rAAV-shVEGFD-injected mice spent
similar amounts of time in the different quadrants (F[3,24] =
1.2, p = NS). This suggests that the rAAV-shVEGFD-injected
mice did not develop a spatial searching strategy, pointing to
spatial memory impairment in these mice. Swimming speed
was not different between the two groups (Figure 8F, main effect
of treatment: F[1,13] = 3.94, p = NS).
To determine whether abnormalities in motivation, motor
coordination, or vision could account for the deficit in spatial
memory, we also trained mice on a visible-platform version of
the water maze, a hippocampus-independent task. In this task,
the mice use a proximal, visual cue to locate the platform (Fig-
ure 8G). rAAV-shSCR- and rAAV-shVEGFD-injected mice
showed similar escape latencies to find the visible platform
(main effect of training session: F[2,26] = 7.12, p < 0.01; main
effect of treatment: F[1,13] = 0.36, p = NS), demonstrating that
both groups acquired the task (Figure 8G). Overall, these results
suggest that rAAV-shVEGFD-injected mice have impaired
spatial memory.
In the contextual fear conditioning, mice learn the association
between an aversive stimulus, a mild foot shock, and the context
in which it was delivered. Inmice that have formed an associative
memory, a second exposure to the same context induces a fear-
ful response expressed as freezing or immobility, parameters
used to quantify the formation of memory (Maren, 2001). We
found that mice stereotaxically injected with rAAV-shVEGFD
showed significantly lower levels of freezing during the 24 hr
test session than didmice injected with rAAV-shSCR (Figure 8H).
The reduction in freezing levels was not due to decreased loco-
motor activity or pain sensitivity because the basal exploratory
activity and reaction to shock during the training session were
not different between the two groups (Figures 8I and 8J). These
findings together with the results obtained with the Morris water
maze indicate that VEGFD is important for memory formation.
DISCUSSION
In this study, we identify VEGFD as a regulator of neuronal
dendrite geometry. VEGFD mediates the effects of synaptic
activity and nuclear calcium-CaMKIV signaling on the mainte-
nance of complex dendrite arborization, which is necessary for
memory formation.
Nuclear Calcium, Dendrite Geometry, and Cognition
Neurons, even once fully developed, remain plastic and undergo
activity-dependent functional or structural alterations. Changes
in gene expression – induced by synaptic activity and calcium
transients propagating toward and into the nucleus (Chawla
et al., 1998; Hardingham et al., 1997, 2001; Zhang et al., 2009) –
are often essential for the long-term maintenance of adaptive re-
sponses (Hardingham and Bading, 2010; Greer and Greenberg,
Figure 8. RNAi-Mediated Suppression of
VEGFD Expression In Vivo Affects Den-
dritic Morphology and Impairs Memory
Formation
(A) Golgi-stained CA1 pyramidal neurons from the
ipsilateral and contralateral hemispheres of mice
stereotaxically injected into the hippocampus with
rAAV-shVEGFD, rAAV-emptymC, or rAAV-shSCR.
Representative tracings of the basal dendritic tree
are shown. Scale bar = 10 mm.
(B and C) Sholl analysis and analysis of total
dendritic length of CA1 Golgi-stained pyramidal
neurons from the ipsilateral and contralateral
hippocampus of mice stereotaxically injected into
the hippocampus with the indicated constructs.
Twenty neurons for each condition obtained from
four injected animals per construct were analyzed.
(D) Mean escape latency during acquisition of the
hidden-platform version of the Morris water maze
(rAAV-shVEGFD, n = 8; rAAV-shSCR, n = 7).
(E) Mean percent time spent in each quadrant
during the probe trial test of the Morris water
maze. T, target quadrant; CW, clockwise quadrant
in relation to target; CCW, counterclockwise
quadrant in relation to target; O, opposite quad-
rant in relation to target (rAAV-shVEGFD, n = 8;
rAAV-shSCR, n = 7).
(F) Mean swimming speed during acquisition of
the hidden-platform version of the Morris water
maze (rAAV-shVEGFD, n = 8; rAAV-shSCR, n = 7).
(G) Mean escape latency during acquisition of the
visible-platform version of the Morris water maze
(rAAV-shVEGFD, n = 8; rAAV-shSCR, n = 7).
(H) Long-term contextual fear memory. Mice were
injected with rAAV-shVEGFD or rAAV-shSCR;
results are expressed as the percentage of time
spent immobile during the contextual memory test
24 hr after training (rAAV-shVEGFD, n = 10; rAAV-
shSCR, n = 11).
(I) Speed of movement during the 2 s electric foot
shock delivered in training session of animals
represented in (H) (rAAV-shVEGFD, n = 10; rAAV-
shSCR n = 11).
(J) Distance traveled during the initial 2.5 min
exposure to the training chamber of animals
represented in (H) (rAAV-shVEGFD, n = 10; rAAV-
shSCR, n = 11).
Statistically significant differences (ANOVA fol-
lowed by Tukey’s post hoc test for morphometric,
repeated-measures ANOVA and one-way ANOVA followed by Tukey’s post hoc test for Morris water maze and Student’s t test for behavioral analysis) are
indicated with asterisks (*p < 0.05, **p < 0.005, ***p < 0.0005). Bars represent mean ± SEM. See also Figure S4.
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receiving endsof neurons, are prime targets for activity-regulated
structural alterations. The geometry of dendrites specifies the
connectivity of neurons and strongly influences how signals are
integrated and transmitted to the cell soma and therefore also
which output is produced. Changes in the lengths and branching
patterns of dendrites would be expected to alter not only the
performance of a neuron but also the computational power of
the network the neuron is part of, ultimately causing changes in
the organism’s behavior. Support for such a link between
dendritic architecture and cognitive abilities comes from theoret-
ical considerations and mathematical modeling (Ha¨usser et al.,2000; Segev and London, 2000) aswell as frombrainmorphology
studies of neurological diseases. In particular, shortening and
simplification of dendrites have been observed in a variety of
disorders that are associatedwithmental retardation or cognitive
deficits, including genetic abnormalities, such as Down syn-
drome or Rett syndrome (Kaufmann andMoser, 2000), neurode-
generative conditions, including Alzheimer’s disease and aging
(Dickstein et al., 2007), metabolic dysfunctions (DeLong, 1993;
Patil et al., 2007), and infection with human immunodeficiency
virus (Masliah et al., 1997). Intrinsic, predetermined genetic
programs and cell-autonomous mechanisms have been shown
to determine dendrite morphogenesis in developing neuronsNeuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc. 127
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2004; Corty et al., 2009). However, there is an increasing appreci-
ation of the influence of the electrical activity of neurons on
dendrite arborization (Zhang and Poo, 2001; Chen and Ghosh,
2005). We show here that VEGFD plays a central role in this
process; as a target of nuclear calcium-CaMKIV signaling, it links
basal neuronal activity to the control of total dendrite length and
branching patterns, thereby providing neurons of the adult
nervous system with the structural features needed for proper
cognitive performance of the organism. These findings explain
why interference either with nuclear calcium signaling or with
CaMKIV activity compromises the ability of mice to form long-
term memories (Limba¨ck-Stokin et al., 2004; Kang et al., 2001).
Theyalsosuggestagenerallyapplicableconcept, inwhich impair-
ments of synaptic transmission, e.g., because of synapse loss in
aging or Alzheimer’s disease (LaFerla, 2002; Shankar et al.,
2007; Kuchibhotla et al., 2008) and/or malfunctioning of activity-
induced calcium signaling toward and within the cell nucleus
(‘‘nuclear calciopathy,’’ Zhanget al., 2011)may lead to a decrease
in VEGFD expression, followed by a reduction in dendrite
complexity, and finally, an emergence of cognitive deficits. Strat-
egies aimed at maintaining or restoring appropriate dendrite
lengths and branching patterns—either through supplementation
of VEGFD or enhancement of nuclear calcium signaling—may
therefore represent avenues for the development of effective
therapies for age- and disease-related cognitive dysfunction.
Anti-VEGFD Cancer Treatment and Compromised
Brain Function
Several members of the VEGF family, including VEGFD, are well-
known angiogenic and lymphangiogenic mitogens that drive the
formation of blood vessels and lymphatic vasculature in healthy
tissues. VEGFD can also enhance the formation of tumor
lymphatics, thereby promoting tumor growth and the lymphatic
spreadof cancercells (Stackeret al., 2001). Indeed,VEGFD levels
in cancer patients correlate with parameters that indicate a poor
clinical prognosis (Achen and Stacker, 2008). Consequently,
tremendous efforts are presently being directed toward the
development and use of VEGF-targeted drugs as antiangiogenic
and antilymphangiogenic treatments. These drugs are intended
to inhibit the growth of tumors by cutting off their blood supply
and blocking themetastatic spread of tumor cells to lymph nodes
via the lymphatic vasculature (Heath and Bicknell, 2009). The
unexpected role we have uncovered for VEGFD in the control of
dendritic architecture and cognitive function thus calls for caution
in the use of blockers of VEGFD signaling as a cancer therapy.
EXPERIMENTAL PROCEDURES
Hippocampal Cultures and Transfection
Hippocampal neurons from newborn C57BL/6 mice were cultured as
described (Bading and Greenberg, 1991; Zhang et al., 2011). Experiments
were done after a culturing period of 10–14 DIV. DNA transfection was done
on DIV 8 by using Lipofectamine 2000 (Invitrogen, San Diego, CA) as described
(Wiegert et al., 2007). For the studies on dendrite morphology, neurons were
analyzed 4–5 days after transfection.
Stereotaxic Delivery of rAAVs
rAAVs were delivered by stereotaxic injection into the right dorsal hippo-
campus of 2-month-old male C57BL/6 mice. For the Golgi staining-based128 Neuron 71, 117–130, July 14, 2011 ª2011 Elsevier Inc.morphometric analysis, viral particles were unilaterally injected over a period
of 20 min at the following coordinates relative to Bregma: anteroposterior,
2.1 mm; mediolateral, 1.4 mm; and dorsoventral, 1.4 to 1.8 mm from
the skull surface. For behavior experiments mice were injected bilaterally.
Morphometric Analyses
For three-dimensional Sholl analysis (Sholl, 1953), total dendritic length and
spine morphology were calculated by using Object-Image freeware software
with a specific set of macros (written by Dr. E. Ruthazer, McGill University,
Quebec, Canada). Briefly, a z-stack acquisition was imported, calibrated in
Object-Image, and manually traced. Total dendritic length was then com-
puted. For Sholl analysis, the shell interval was set at 5 mm. All analyses
were performed blind. In all in vitro experiments, for each condition, aminimum
of 12 neurons from 3 independent preparations was analyzed. For the Golgi
staining, quantifications of 20 neurons for each condition from 4 different
injected animals per viral construct were traced and analyzed.
MEA Recordings
MEA recordings were done as described (Arnold et al., 2005). From DIV 7 to
DIV 13, recordings of spontaneous network activity were acquired for 5 min
once per day.
Patch-Clamp Recordings
Whole-cell patch-clamp recordings were made at room temperature from
cultured hippocampal neurons plated on coverslips secured with a platinum
ring in a recording chamber (Open Access Chamber-1, Science Products
GmbH, Hofheim, Germany) mounted on a fixed-stage upright microscope
(BX51WI, Olympus, Hamburg, Germany). Differential interference contrast
optics, infrared illumination, and a CCD camera (PCO, Visitron Systems, Puch-
heim, Germany) connected to a contrast enhancement unit (Argus, Hama-
matsu, Herrsching am Ammersee, Germany) were used to view neurons on
a videomonitor. Recordingsweremadewith aMulticlamp 700A amplifier, digi-
tized through a Digidata 1322A A/D converter, and acquired by using pClamp
software (Molecular Devices, Sunnyvale, CA). All membrane potentials were
corrected for the calculated junction potential of 11 mV (JPCalc program
by Dr. Peter H. Barry). mEPSCs and whole-cell AMPA (10 mM, 6 ml/min, Bio-
trend) responses were recorded as previously described (Wiegert et al.,
2009) except for the solutions (see Supplemental Information) and except
that a holding potential of –71 mV was used and both TTX (1 mM, Biotrend,
Cologne, Germany) and gabazine (5 mM, Biotrend) were included in the
ACSF. TTX was applied before gabazine to prevent the induction of action
potential bursting. Access (7–18 MU) and membrane resistance (see Table
S1) were monitored before and after mEPSC recordings and data were
rejected if changes greater than 20% occurred.
Behavioral Experiments
The behavioral experiments started 3 weeks after stereotaxic delivery of
rAAVs. Mice were habituated to the experimental room and handled once a
day for 3 consecutive days before testing started. Two different sets of mice
were used for Morris water maze and contextual fear conditioning experi-
ments. At the end of the experiments, virus infection was assessed. For details
on the behavioral experiments see Supplemental Information.
Data Analysis
All plotted data representmean ± SEM. ANOVAwith Tukey’s post hoc test was
used for statistical analyses except where stated otherwise. In those experi-
ments where only two conditions are tested, comparisons were made by using
a Student’s t test for independent samples. In the Morris water maze experi-
ment, repeated-measures ANOVA and one-way ANOVA were used to analyze
acquisition curves and probe trials, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2011.04.022.
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